Facebook Twitter Instagram
    TOPTHENEWS
    • Home
    • Business
    • Technology
    • Digital Marketing
    • Entertainment
    • News
    • Health
    • Law
    • Lifestyle
    • Sports
    TOPTHENEWS
    Home»Covid 19»J & J pauses Coronavirus vaccine tests after participants become ill
    Covid 19

    J & J pauses Coronavirus vaccine tests after participants become ill

    AlexBy AlexOctober 14, 2020No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Highlights: Johnson & Johnson said Monday that it temporarily suspended clinical tests of its Covid-19 vaccine contenders due to an undescribed disease among study competitors. They were detaining one of the most profiled tries to control the global epidemic.

    WASHINGTON: J & J said Monday that it temporarily suspended its Covid-19 vaccine contenders clinical tests to an undescribed disease among study competitors. It was delaying one of the most profiled tries to control the global epidemic.

    The agency said an independent and safety are observing board and the agency’s clinical and welfare physicians review and evaluate competitors’ illness in a statement.

    On Tuesday morning, the quarterly financial results report, J&J said that such breaks are regular in large-scale tests, including several thousand public. It said the “study break” in administering the dose to vaccine contender was different from the “regulatory hold” needed by health administrations.

    In the Vanderbilt University School of Medicine, the Professor of Spreading Diseases, Dr. William Schaffner, said in an email that “everyone is on the lookout for what happened to AstraZeneca,” also said that it could pull up to a week to collect more details. He further added, “It’s going to be a severe unpleasant incident. If it were something like prostate cancer, uncontrolled diabetes, or a heart attack – they couldn’t terminate it for any reason. Maybe it could be a nervous event”.

    The previous month, J&J said it’s trial Covid-19 vaccine had developed a strong resistance in opposition to the novel coronavirus in early to mid-term clinical tests. The agency began trials of a final 70,000 people, with results expected later this year.

    Johnson and Johnson reduced to give details about the illness. Some participants in the study received a placebo. It was not always logical whether any person suffering from a severe unpleasant event in a clinical test received a placebo or the cure.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Alex
    • Website

    Related Posts

    How HYIP projects are born

    January 17, 2023

    Three Strategies You Should Consider Before Buying a Home

    December 26, 2022

    What You Need to Know Before Investing in a Trading Robot in 2023: A Comprehensive Guide

    December 16, 2022

    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    Recent Posts

    An Analysis of Messi’s Signature Playing Style

    March 23, 2023

    Common Reasons that Lead to the Rejection of a Personal Loan

    March 20, 2023

    Common Misconceptions About Online Gambling In Malaysia

    March 19, 2023

    The Popularity of Cricket in Africa

    March 18, 2023
    Categories
    • All
    • Apps and Software
    • Automotive
    • Beauty
    • Business
    • Covid 19
    • Digital Marketing
    • Education
    • Entertainment
    • Fashion
    • fitness
    • Food
    • Games
    • Health
    • Home
    • Law
    • Lifestyle
    • Net Worth
    • News
    • Pet
    • Phone
    • Programming
    • Real Estate
    • Social
    • Software
    • Sports
    • Tech
    • Technology
    • Travel
    • Contact Us
    • Privacy Policy
    Topthenews © Copyright 2023, All Rights Reserved

    Type above and press Enter to search. Press Esc to cancel.